Hvem er vi

Lundbeckfonden Emerge is led by Christian E. Elling who works closely with the team of Lundbeckfonden Ventures and Lundbeckfonden as well as outside resources complementing the skillset of Lundbeckfonden Emerge.

Lundbeckfonden Emerge

Christian Elling

Managing Partner

Paul Little

Operating Partner

Lundbeckfonden Emerge


Ny Partner til Lundbeckfonden Emerge
17. december 2018
IO Biotech announces first patient dosed in global phase I/II clinical trial for the first-line treatment of patients with metastatic non-small cell lung cancer
2. oktober 2018
Dermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral Lichen Planus
28. juli 2018